ArticleJCI insight2023

Multiomics of HER2-low triple-negative breast cancer identifies a receptor tyrosine kinase-relevant subgroup with therapeutic prospects.

Lie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.